9.4 Possible Adverse Side Effects
Possible adverse effects include but are not limited by: discomfort or pain, excessive
skin redness (erythema) and/or swelling (edema), damage to natural skin texture
(crust, blister, and burn), change of pigmentation (hyper- and hypo-pigmentation),
and scarring.
Erythema lasting not longer than 24h and edema for 1-3 weeks is a typical skin
reaction to the Fractora treatment.
Crusting from the ablated dots will exfoliate naturally after 1-3 weeks.
Occasionally, there is a potential low-level stimulation of branches of the facial nerve
and there will be some involuntary contraction of the underlying facial muscle. This is
transient and is not harmful, as the Fractora effect diminishes at the deeper level
where parts of the facial nerve lie above the muscles.
The patient must understand the importance of pre-treatment and post-treatment
instructions and that failure to comply with these instructions may increase the
probability of complications.
9.5 Pre-treatment Recommendations
During the patient’s first visit the treating attendant should:
▪ Complete or update the patient's medical and physical history.
▪ Exclude from treatment anyone with the listed contraindications.
▪ Determine why the patient is seeking treatment and what his/her expectations
are.
▪ Determine accurately the patients Fitzpatrick skin type.
▪ Inform the patient about treatment arrangement, typical treatment results and
possible side effects and discomfort.
▪ Instruct the patient about the safety warnings.
▪ Advise the patient to avoid skin irritation or intentional skin tanning. Sunscreen is
advisable when outdoors during daylight hours
▪ Asian patients and those with skin types IV-VI should be treated gradually by
bleaching products 6 weeks prior treatment and stop at least 48 hours prior
Fractora treatment to minimize risk of post inflammatory hyper-pigmentation.
▪ Prophylactic antiviral therapy should be prescribed for patients with history of
cold sores (Herpes Simplex) when treating around the mouth.
▪ Stop anticoagulants 7-10 days prior to treatment, if medically permitted.
To Next Page
Loading...
